SEATTLE — There's new hope for people in the early stages of Alzheimer's disease. A new medication called donanemab appears ...

Studies in neuroscience with applications to humans offer clues about what makes us start eating, and when we stop.

In new research published in Nature, scientists have produced the first comprehensive atlas of the tiny energy producers in ...